ICP
PAHC icon

Interchange Capital Partners’s Phibro Animal Health PAHC Stock Holding History

Interchange Capital Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-476
Closed -$9K – 843
2020
Q4 		$9K Buy
+476
New +$8.76K ﹤0.01% 820

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Interchange Capital Partners's PAHC Position: Q1 2021 in Review

Interchange Capital Partners sold out of Phibro Animal Health (PAHC) in Q1 2021, closing a stake of 476 shares — an estimated $9K sold.

Interchange Capital Partners first reported a position in PAHC in Q4 2020 and held it in 1 quarter. The position peaked at $9K in Q4 2020. 141 funds tracked by Wall St. Rank hold PAHC as of Q1 2021.

  • Interchange Capital Partners reported no remaining Phibro Animal Health position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 476 Phibro Animal Health shares in Q1 2021, an estimated $9K.
  • Interchange Capital Partners first reported a position in Phibro Animal Health in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's Phibro Animal Health position peaked at $9K in Q4 2020.
  • 141 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.